Both tirzepatide and semaglutide were associated with increased risk of gastrointestinal adverse events compared with placebo at all doses, tirzepatide 15mg was associated with the highest risk for nausea (3.6 times), vomiting (4.4 times) and diarrhoea (2.0 times)
How to think about supplements on a GLP-1 (a simple hierarchy) Ranked by evidence strength: Tier 1: protein (1.21.6 g/kg/day) and resistance training 23 sessions weekly
The retrospective study of intra-articular knee injections noted no significant adverse events in 16 participants
Tirzepatide, also known as Zepbound for weight loss, is a revolutionary FDA-approved medication that addresses obesity by acting on two key hormonal pathways
But, its safety and effectiveness in kids depend on their age, diet, and health
the commercial growth of IMCIVREE